A class action brought on behalf of 40,000 customers has been launched against two Queensland energy generators who are accused of ‘gaming’ the energy pricing system and artificially inflating consumer prices.
While there was no shortage of pain and challenges for law firms as the coronavirus raged across the globe last year, a number of big firms also felt the sting of litigation from disgruntled clients, partners and employees.
Two law firms that have filed competing class action against AMP over allegedly excessive insurance premiums have changed tack and agreed to consolidate the proceedings.
Freedom Foods and its auditor Deloitte have been hit with a shareholder class action after a shock announcement last week of more than $590 million in write-downs stemming from accounting irregularities.
Freedom Foods and its auditor Deloitte are facing a class action investigation after a bombshell announcement of more than $590 million in write-downs stemming from accounting irregularities stretching back several years.
Facing an ASIC enforcement action over alleged breaches of Australian credit laws, payday lenders BHF Solutions and Cigno claim they did not need a licence to issue loans to hundreds of thousands of consumers.
A showdown over two competing class actions against AMP is set down for December, and the applicants will have to persuade the judge overseeing the cases that they should not be consolidated.
Over-the-counter derivative issuers AGM Markets, OT Markets and Oxifin Tech have been ordered to pay a total of $75 million in penalties after a ruling that they engaged in unconscionable conduct causing losses of over $30 million to unsophisticated investors seeking what a judge called “financial heroin hits”.
Piper Alderman has struck back at a sex discrimination lawsuit brought by a former administrative assistant, admitting that while a law firm partner did tell her to “go spend time with your kids” following a meeting in which she was made redundant, the comment had been taken out of context.
Fifty horse owners may face cross-examination regarding adverse effects allegedly caused by Zoetis’ Hendra virus vaccine, with the company warning a four-week hearing scheduled to begin in March may be insufficient to deal with the horse owners’ evidence.